SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-000694
Filing Date
2019-01-04
Accepted
2019-01-04 17:07:23
Documents
9
Effectiveness Date
2019-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv510157_8k.htm DEFA14A 42553
2 EXHIBIT 2.1 tv510157_ex2-1.htm EX-2.1 690839
3 EXHIBIT 10.1 tv510157_ex10-1.htm EX-10.1 59627
4 EXHIBIT 10.2 tv510157_ex10-2.htm EX-10.2 59684
5 EXHIBIT 10.3 tv510157_ex10-3.htm EX-10.3 23635
6 EXHIBIT 10.4 tv510157_ex10-4.htm EX-10.4 23232
7 EXHIBIT 99.1 tv510157_ex99-1.htm EX-99.1 24344
8 GRAPHIC image_001.jpg GRAPHIC 3385
9 GRAPHIC image_002.jpg GRAPHIC 3406
  Complete submission text file 0001144204-19-000694.txt   934656
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37544 | Film No.: 19510998
SIC: 2836 Biological Products, (No Diagnostic Substances)